Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
89.07
-0.17 (-0.20%)
Aug 12, 2026, 11:56 AM EDT - Market open

Arrowhead Pharmaceuticals Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Buy
Maintains
$95$100
BuyMaintains$95$100+12.28%Aug 7, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$115$120
BuyReiterates$115$120+34.73%Aug 6, 2026
Morgan Stanley
Morgan Stanley
Buy
Reiterates
$120
BuyReiterates$120+34.73%Aug 5, 2026
B. Riley Securities
B. Riley Securities
Buy
Reiterates
$123
BuyReiterates$123+38.10%Aug 5, 2026
RBC Capital
RBC Capital
Buy
Maintains
$100
BuyMaintains$100+12.28%Aug 5, 2026
Piper Sandler
Piper Sandler
Buy
Reiterates
$126
BuyReiterates$126+41.47%Aug 5, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Reiterates
$98$104
BuyReiterates$98$104+16.77%Aug 5, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$100
BuyReiterates$100+12.28%Aug 5, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.